6 posts tagged NOVN

These stocks are down in price and up in volume by: RXI +2,248% GLP +696% BSC +668% NOVN +567% TNDM +481% SIGM +395% DPM +382% MW +366% BCA +363% IRS +320% BG +302% FIF +293% RAVN +281% HMIN +263% HANS +216% TRK +201% AU +177% AXE +173% VTIV +139% PPDI +131% ULTR +117% TBSI +106% PPDI +105% ICON

The 13Fs came flying in this week. I hope you were able to keep up with all the news. If not, Value Investing News has got your back. Here are the top stories our members unearthed this week: Brush Up on Sherwin-Williams (SHW), But Still Too Soon to Buy Business Wire Canada Opening Reception: A

The Novartis (NOVN) put got exercised, which means that I bought the stock at CHF 65.00

The naked put on Novartis (NOVN) 65/DEC expired today.

Atticus Lowe & Lance Helfert at the 3rd Annual New York Value Investing Congress reported by Marcelo Lima. Filed under: From the co-founders — Tags: Atticus Lowe, Lance Helfert, Marcelo Lima, Noven Pharmaceuticals, NOVN — Jane Scottsdale @ 8:13 am Atticus Lowe & Lance Helfert at the 3rd Annual New York Value Investing Congress reported by Marcelo Lima.

We had a correspondent at the Value Investing Congress today. Here are some the headlines with links to the articles at our main site: 3:36PM Second Curve Capital's Tom Brown Loves First Marblehead (FMD) 3:26PM Second Curve Capital's Tom Brown Thinks We May Be Near A Bottom 3:08PM - Steve Tananbaum,